Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Peptoids with antibacterial activity designed by Chiron and collaborators

July 20, 1999

Pharmacia & Upjohn's new oxazolidinones exhibit weak or no MAO inhibition

July 20, 1999

Welsh technology applicable to antiviral drug discovery licensed to Glaxo Wellcome

July 19, 1999

Naturally produced depsipeptides found to possess antibacterial and antiinflammatory activity

July 19, 1999

ViroPharma announces successful VRI program with pleconaril

July 19, 1999

Clinical trial program for daptomycin updated by Cubist

July 16, 1999

Ramoplanin successfully completes phase II as VRE therapy

July 16, 1999

Proposed market formulation of Ro-64-0796 bioequivalent to other capsule and liquid formulations

July 15, 1999

Salix updates rifaximin clinical development as BID therapy

July 15, 1999

StressGen begins second phase I safety trial of HspE7

July 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...